An angiogenesis claim should identify the assay and the tissue context. This report did not find one uniform response across its experimental systems. Primary report
Study snapshot
The investigators compared cell-culture observations with injured muscle and tendon models, including crushed and transected tissue. They reported no direct angiogenic effect in the tested cultures. In healing tissues, immunohistochemical findings using VEGF, CD34, and factor-VIII markers supported an injury-associated angiogenic response with BPC-157. Primary report
Our appraisal: a model difference is information
The negative culture result belongs in the summary. It may help define conditions under which a proposed response appears, but it does not itself identify why the systems differ. Cell composition, injury signals, exposure, and assay design are possibilities to investigate, not established explanations.
Marker staining also needs a precise interpretation. Evidence of vascular-associated proteins does not automatically demonstrate that new vessels are mature, perfused, durable, or beneficial to function. Those properties require measurements appropriate to each question.
This report should not be blended uncritically with another angiogenesis paper that uses different cells or injury conditions. Apparent disagreement may reflect different tests, but that reconciliation needs methods-level comparison. It should not be solved by selecting only the most favorable abstract.
Full review should examine the timing of tissue collection, anatomical sampling, blinded scoring, and the link between vascular observations and functional healing. The paper supports a context-dependent experimental observation. It does not establish that more angiogenesis is always desirable, that every wound responds similarly, or that the result translates to human treatment.
Frequently asked questions
Did the culture assay show a direct angiogenic effect?
The report says it did not.
Were injured tissues also examined?
Yes, muscle and tendon models.
Which evidence layer supported the tissue finding?
Immunohistochemical vascular markers.
Does staining prove functional blood flow?
Not by itself.
Should a negative model result be omitted?
No.
Does this settle disagreement with other assay systems?
No; their methods need comparison.
What conclusion is supported?
A model-dependent preclinical finding, not universal human wound-healing efficacy.